RYR2 and Malignant hyperthermia: Studies investigating gain-of-function human RYR mutations have demonstrated that specific RYR mutations confer sex-, gene-, and dose-dependent vulnerability to pharmacological (halogenated anesthetic) and environmental (heat) stressors that trigger malignant hyperthermia and subsequent muscle damage in otherwise asymptomatic individuals [271,272].